Achieve Life Sciences
Stock Forecast, Prediction & Price Target
Achieve Life Sciences Financial Estimates
Achieve Life Sciences Revenue Estimates
Achieve Life Sciences EBITDA Estimates
Achieve Life Sciences Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $16.41M Low: $16.41M High: $16.41M avg. 0% | Avg: $37.71M Low: $37.71M High: $37.71M avg. 129.75% | Avg: $123.97M Low: $123.97M High: $123.97M avg. 228.71% | Avg: $240.57M Low: $240.57M High: $240.57M avg. 94.04% |
Net Income
% change YoY
| $-32.90M N/A | $-41.87M -27.27% | $-29.81M 28.79% | Avg: $-39.13M Low: $-23.19M High: $-14.07M avg. -31.25% | Avg: $-11.50M Low: $-16.25M High: $6.93M avg. 70.60% | Avg: $14.01M Low: $14.01M High: $14.01M avg. 221.79% | Avg: $65.92M Low: $65.92M High: $65.92M avg. 370.51% |
EBITDA
% change YoY
| $-33.09M N/A | $-40.8M -23.28% | $-26.73M 34.47% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$4.05 N/A | -$3.95 2.46% | -$1.5 62.02% | Avg: -$0.95 Low: -$1.17 High: -$0.71 avg. 36.55% | Avg: -$0.34 Low: -$0.82 High: $0.35 avg. 63.92% | Avg: $0.71 Low: $0.71 High: $0.71 avg. 305.82% | Avg: $3.33 Low: $3.33 High: $3.33 avg. 370.51% |
Operating Expenses
% change YoY
| $33.09M N/A | $40.8M 23.28% | $27.02M -33.76% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Achieve Life Sciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 157.91% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -23.19M, average is -39.13M and high is -14.07M.
What is Achieve Life Sciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 113.12% in 2025-2028.
We have gathered data from 4 analysts. Their low revenue estimate is $16.41M, average is $16.41M and high is $16.41M.
What is Achieve Life Sciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 194.20% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$1.17, average is -$0.95 and high is $-0.71.
What is the best performing analyst?
In the last twelve months analysts have been covering Achieve Life Sciences stock. The most successful analyst is Francois Brisebois.